Long-lasting tumor response on short-time administration of vemurafenib—A case report

Por Mitzel, Heidrun, Grabbe, Stephan, Loquai, Carmen
Publicado no JAAD Case Rep (2014)

Long-term survival of patients after ipilimumab and hypofractionated brain radiotherapy for brain metastases of malignant melanoma: sequence matters

Por Schmidberger, Heinz, Rapp, Matthias, Ebersberger, Anne, Hey-Koch, Silla, Loquai, Carmen, Grabbe, Stephan, Mayer, Arnulf
Publicado no Strahlenther Onkol (2018)

Screening for Distress in Routine Oncological Care—A Survey in 520 Melanoma Patients

Por Loquai, Carmen, Scheurich, Vera, Syring, Nils, Schmidtmann, Irene, Rietz, Stephan, Werner, Andreas, Grabbe, Stephan, Beutel, Manfred E.
Publicado em 2013

B-Raf inhibitor vemurafenib in combination with temozolomide and fotemustine in the killing response of malignant melanoma cells

Por Roos, Wynand P., Quiros, Steve, Krumm, Andrea, Merz, Stephanie, Switzeny, Olivier Jérôme, Christmann, Markus, Loquai, Carmen, Kaina, Bernd
Publicado no Oncotarget (2014)

Real-World Use of Talimogene Laherparepvec in German Patients with Stage IIIB to IVM1a Melanoma: A Retrospective Chart Review and Physician Survey

Por Mohr, Peter, Haferkamp, Sebastian, Pinter, Andreas, Weishaupt, Carsten, Huber, Margit A., Downey, Gerald, Öhrling, Katarina, Loquai, Carmen, Louie, Karly S.
Publicado no Adv Ther (2018)

Progression patterns under BRAF inhibitor treatment and treatment beyond progression in patients with metastatic melanoma

Por Hassel, Jessica C., Buder‐Bakhaya, Kristina, Bender, Carolin, Zimmer, Lisa, Weide, Benjamin, Loquai, Carmen, Ugurel, Selma, Slynko, Alla, Gutzmer, Ralf
Publicado no Cancer Med (2017)

Willingness to pay for a cure of low-risk melanoma patients in Germany

Por Augustin, Matthias, Blome, Christine, Forschner, Andrea, Gutzmer, Ralf, Hauschild, Axel, Heinzerling, Lucie, Livingstone, Elisabeth, Loquai, Carmen, Schadendorf, Dirk, Utikal, Jochen, Wagner, Tobias, Wilden, Sophia, Kähler, Katharina C.
Publicado no PLoS One (2018)

The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy: a survey in German melanoma patients and their treating physicians

Por Kähler, Katharina C., Blome, Christine, Forschner, Andrea, Gutzmer, Ralf, Hauschild, Axel, Heinzerling, Lucie, Livingstone, Elisabeth, Loquai, Carmen, Müller-Brenne, Tina, Schadendorf, Dirk, Utikal, Jochen, Wagner, Tobias, Augustin, Matthias
Publicado no Oncotarget (2018)

Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma

Por Zimmer, Lisa, Eigentler, Thomas K., Kiecker, Felix, Simon, Jan, Utikal, Jochen, Mohr, Peter, Berking, Carola, Kämpgen, Eckhart, Dippel, Edgar, Stadler, Rudolf, Hauschild, Axel, Fluck, Michael, Terheyden, Patrick, Rompel, Rainer, Loquai, Carmen, Assi, Zeinab, Garbe, Claus, Schadendorf, Dirk
Publicado no J Transl Med (2015)

Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG “GERMELATOX survey”) versus melanoma recurrence to quantify patients’ relative values for ad...

Por Kaehler, Katharina C., Blome, Christine, Forschner, Andrea, Gutzmer, Ralf, Haalck, Thomas, Heinzerling, Lucie, Kornek, Thomas, Livingstone, Elisabeth, Loquai, Carmen, Maul, Lara Valeska, Lang, Berenice M., Schadendorf, Dirk, Stade, Barbara, Terheyden, Patrick, Utikal, Jochen, Wagner, Tobias, Hauschild, Axel, Garbe, Claus, Augustin, Matthias
Publicado no Medicine (Baltimore) (2016)

The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma: A retrospective multicenter study

Por Tietze, Julia K., Forschner, Andrea, Loquai, Carmen, Mitzel-Rink, Heidrun, Zimmer, Lisa, Meiss, Frank, Rafei-Shamsabadi, David, Utikal, Jochen, Bergmann, Maike, Meier, Friedegund, Kreuzberg, Nicole, Schlaak, Max, Weishaupt, Carsten, Pföhler, Claudia, Ziemer, Mirjana, Fluck, Michael, Rainer, Jessica, Heppt, Markus V., Berking, Carola
Publicado no Oncotarget (2018)

Pimasertib Versus Dacarbazine in Patients With Unresectable NRAS-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover

Por Lebbé, Celeste, Dutriaux, Caroline, Lesimple, Thierry, Kruit, Willem, Kerger, Joseph, Thomas, Luc, Guillot, Bernard, de Braud, Filippo, Garbe, Claus, Grob, Jean-Jacques, Loquai, Carmen, Ferraresi, Virginia, Robert, Caroline, Vasey, Paul, Conry, Robert, Isaacs, Richard, Espinosa, Enrique, Schueler, Armin, Massimini, Giorgio, Dréno, Brigitte
Publicado no Cancers (Basel) (2020)

Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma: a multicenter randomized phase-3 DeCOG trial

Por Ugurel, Selma, Loquai, Carmen, Terheyden, Patrick, Schadendorf, Dirk, Richtig, Erika, Utikal, Jochen, Gutzmer, Ralf, Rass, Knuth, Sunderkötter, Cord, Stein, Annette, Fluck, Michael, Kaatz, Martin, Trefzer, Uwe, Kähler, Katharina, Stadler, Rudolf, Berking, Carola, Höller, Christoph, Kerschke, Laura, Edler, Lutz, Kopp-Schneider, Annette, Becker, Jürgen C.
Publicado no Oncotarget (2017)

Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions

Por Sucker, Antje, Zhao, Fang, Pieper, Natalia, Heeke, Christina, Maltaner, Raffaela, Stadtler, Nadine, Real, Birgit, Bielefeld, Nicola, Howe, Sebastian, Weide, Benjamin, Gutzmer, Ralf, Utikal, Jochen, Loquai, Carmen, Gogas, Helen, Klein-Hitpass, Ludger, Zeschnigk, Michael, Westendorf, Astrid M., Trilling, Mirko, Horn, Susanne, Schilling, Bastian, Schadendorf, Dirk, Griewank, Klaus G., Paschen, Annette
Publicado no Nat Commun (2017)

Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study

Por Heppt, Markus V., Amaral, Teresa, Kähler, Katharina C., Heinzerling, Lucie, Hassel, Jessica C., Meissner, Markus, Kreuzberg, Nicole, Loquai, Carmen, Reinhardt, Lydia, Utikal, Jochen, Dabrowski, Evelyn, Gesierich, Anja, Pföhler, Claudia, Terheyden, Patrick, Thoms, Kai-Martin, Zimmer, Lisa, Eigentler, Thomas K., Kirchberger, Michael C., Stege, Henner M., Meier, Friedegund, Schlaak, Max, Berking, Carola
Publicado no J Immunother Cancer (2019)

Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients

Por Hecht, Markus, Meier, Friedegund, Zimmer, Lisa, Polat, Bülent, Loquai, Carmen, Weishaupt, Carsten, Forschner, Andrea, Gutzmer, Ralf, Utikal, Jochen S, Goldinger, Simone M, Geier, Michael, Hassel, Jessica C, Balermpas, Panagiotis, Kiecker, Felix, Rauschenberg, Ricarda, Dietrich, Ursula, Clemens, Patrick, Berking, Carola, Grabenbauer, Gerhard, Schadendorf, Dirk, Grabbe, Stephan, Schuler, Gerold, Fietkau, Rainer, Distel, Luitpold V, Heinzerling, Lucie
Publicado no Br J Cancer (2018)

Genomic correlates of response to CTLA-4 blockade in metastatic melanoma

Por Van Allen, Eliezer M., Miao, Diana, Schilling, Bastian, Shukla, Sachet A., Blank, Christian, Zimmer, Lisa, Sucker, Antje, Hillen, Uwe, Foppen, Marnix H. Geukes, Goldinger, Simone M., Utikal, Jochen, Hassel, Jessica C., Weide, Benjamin, Kaehler, Katharina C., Loquai, Carmen, Mohr, Peter, Gutzmer, Ralf, Dummer, Reinhard, Gabriel, Stacey, Wu, Catherine J., Schadendorf, Dirk, Garraway, Levi A.
Publicado no Science (2015)

Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: a multicenter retrospective cohort study of the DeCOG

Por Knispel, Sarah, Stang, Andreas, Zimmer, Lisa, Lax, Hildegard, Gutzmer, Ralf, Heinzerling, Lucie, Weishaupt, Carsten, Pföhler, Claudia, Gesierich, Anja, Herbst, Rudolf, Kaehler, Katharina C, Weide, Benjamin, Berking, Carola, Loquai, Carmen, Utikal, Jochen, Terheyden, Patrick, Kaatz, Martin, Schlaak, Max, Kreuter, Alexander, Ulrich, Jens, Mohr, Peter, Dippel, Edgar, Livingstone, Elisabeth, Becker, Jürgen C, Weichenthal, Michael, Chorti, Eleftheria, Gronewold, Janine, Schadendorf, Dirk, Ugurel, Selma
Publicado no J Immunother Cancer (2020)

Acquired BRAF inhibitor resistance: a multicenter meta-analysis of the spectrum and frequencies, clinical behavior, and phenotypic associations of resistance mechanisms

Por Johnson, Douglas B., Menzies, Alexander M., Zimmer, Lisa, Eroglu, Zeynep, Ye, Fei, Zhao, Shilin, Rizos, Helen, Sucker, Antje, Scolyer, Richard A., Gutzmer, Ralf, Gogas, Helen, Kefford, Richard F., Thompson, John F., Becker, Jürgen C., Berking, Carola, Egberts, Friederike, Loquai, Carmen, Goldinger, Simone M., Pupo, Gulietta M., Hugo, Willy, Kong, Xiangju, Garraway, Levi A., Sosman, Jeffrey A., Ribas, Antoni, Lo, Roger S., Long, Georgina V., Schadendorf, Dirk
Publicado no Eur J Cancer (2015)

Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients

Por Amaral, Teresa, Kiecker, Felix, Schaefer, Sarah, Stege, Henner, Kaehler, Katharina, Terheyden, Patrick, Gesierich, Anja, Gutzmer, Ralf, Haferkamp, Sebastian, Uttikal, Jochen, Berking, Carola, Rafei-Shamsabadi, David, Reinhardt, Lydia, Meier, Friedegund, Karoglan, Ante, Posch, Christian, Gambichler, Thilo, Pfoehler, Claudia, Thoms, Kai, Tietze, Julia, Debus, Dirk, Herbst, Rudolf, Emmert, Steffen, Loquai, Carmen, Hassel, Jessica C, Meiss, Frank, Tueting, Thomas, Heinrich, Vanessa, Eigentler, Thomas, Garbe, Claus, Zimmer, Lisa
Publicado no J Immunother Cancer (2020)